Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges
- Resource Type
- Review Article
- Source
- In
Neuroscience and Biobehavioral Reviews July 2020 114:38-52 - Subject
- Language
- ISSN
- 0149-7634